BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 7, 2010
View Archived Issues
Sipuleucel-T is safe and well tolerated in CRPC and ADPC
Read More
CF-101 displays safety and potent anti-inflammatory activity
Read More
Eprosartan/bisoprolol shows efficacy in chronic heart failure and pulmonary hypertension
Read More
Lucinactant protects against IRI in experimental lung transplantation
Read More
Spermine identified as putative biomarker of stroke diagnosis and severity
Read More
Hedgehog signaling inhibitors claimed by Lilly for cancer therapy
Read More
Evotec presents new histamine H3 receptor antagonists
Read More
Biotie Therapies and Wyeth claim new PDE inhibitors
Read More
Boehringer Ingelheim identifies new collagenase 3 inhibitors
Read More
Abbott discloses highlights of first quarter 2010
Read More
Raptor licenses intellectual property related to treatment of Huntington's disease
Read More
FDA advisory committee reviews MedImmune's motavizumab BLA
Read More
FDA advisory committee review of lorcaserin set for September
Read More
Astellas announces second tender offer period for OSI share acquisition
Read More
FDA approves Roche Diagnostics' Elecsys anti-HCV assay
Read More
Aoxing and PPL to codevelop new pain and addiction therapies
Read More
Intercell partners with Inclinix for phase III trial of travelers' diarrhea vaccine
Read More
FDA grants orphan drug status to telatinib for gastric cancer
Read More
YM raises funds for phase II part of CYT-387 trial in myelofibrosis
Read More
CSL Behring's Berinert approved in Canada for HAE
Read More
Cephalon discontinues development of Nuvigil in schizophrenia
Read More
Phase II trial of Ocuseva in retinitis pigmentosa completed
Read More
Nabriva begins phase II BC-3781 trial in skin and skin structure infections
Read More
Tioga begins phase III asimadoline trial in irritable bowel syndrome
Read More
Phase I data presented on HuM195/rGel in advanced myeloid malignancies
Read More
CT-322 is active in phase II trial in recurrent glioblastoma
Read More
